MedTrace Logo

A Novel, Comprehensive Approach to Post-stroke Gait Rehabilitation

NCT04411303 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-11-04

No results posted yet for this study

Summary

The goal of this project is to determine the feasibility and optimal parameters of a novel, comprehensive approach to gait training in individuals with chronic stroke. The comprehensive approach includes biofeedback-based gait training and aerobic exercise intensity-based gait training.

Conditions

  • CVA (Cerebrovascular Accident)

Interventions

BEHAVIORAL

Step length biofeedback

Participants will be provided with visual feedback of their right and left step lengths on a screen in front of a treadmill.

BEHAVIORAL

Propulsive force biofeedback

Participants will be provided with real-time visual feedback of anterior-posterior ground reaction forces of the paretic limb during stance phase on a screen in front of a treadmill.

BEHAVIORAL

Interlimb asymmetry biofeedback

Participants will be provided with visual feedback of stride-by-stride values of their interlimb asymmetry on a screen in front of a treadmill.

BEHAVIORAL

Aerobic intensity-based walking

Participants will walk at three different aerobic intensities. Aerobic intensity will be set based on target heart rate zones calculated with the Karvonen Formula. For low intensity, participants will walk at 30-40% intensity. In moderate intensity conditions, participants will walk at a 50-60% intensity level. In vigorous intensity conditions, participants will walk at an 70-80% intensity level. Aerobic intensity will be manipulated by changing walking speed.

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Kristan Leech, PT, DPT, PhD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-09
Primary Completion
2024-08-14
Completion
2025-12-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04411303 on ClinicalTrials.gov